Previous Page  7 / 20 Next Page
Information
Show Menu
Previous Page 7 / 20 Next Page
Page Background

Page 22

Notes:

June 10-11, 2019 | Edinburgh, Scotland

Central Nervous System and Therapeutics

2

nd

International Conference on

Journal of Neurology and Neurorehabilitation Research | Volume 4

allied

academies

Nitrite and other NO donors for treatment of Subarachnoid Hemorrhage

Ryszard M Pluta

National Institute of Health, USA

F

ollowing aneurysmal subarachnoid hemorrhage (aSAH),

oxygenated, high-pressure blood forms a clot in the

subarachnoid space increasing intracranial pressure (ICP),

evoking early brain injury (EBI), ultra-early (<6hr) vasospasm

and cortical and/or global cerebral ischemia. During the

subsequent week(s), 70% of patients develop delayed

vasospasm, and up to 50%-delayed cerebral ischemia (DCI)

both fortelling poor outcome. The exact pathomechanism(s)

responsible for those events remains debated. However, it

is widely accepted that oxyhemoglobin and its degradation

products being neurotoxic and NO scavengers, derail

vasodilatory activity of endothelial and neuronal NO-

synthases evoking endothelial dysfunction. Decreased

NO - availability in the arterial wall endothelium coupled

with depletion of brain NO storages by a transient ischemia

increasing a local concentration of deoxy-hemoglobin

affects conductive arteries and microcirculation, limits

perfusion of the cortex, triggers local vasospasm as well as

spreading depolarizations leading to spreading ischemia.

In experimental and clinical settings an intravenous infusion

and local administration of NO gas and different NO-donors

demonstratedbeneficial effect limiting braindamage, delayed

cerebral infarctions, vasospasm and improving the outcome.

This presentation addresses historical data of NO-dependent

relief of vasospasm, prevention of delayed brain infarctions,

presents its impact on the outcome in the experimental and

clinical setting after SAH, and suggests some future venues of

NO-related research.

Speaker Biography

Ryszard M Pluta was born and educated in Warsaw, Poland where I

obtained my medical, neurosurgical, doctoral degrees and postdoctoral

award in the field of Neurosurgery from the Medical Research Center

of Polish Academy of Sciences and the Jerzy and Krystyna Chorobski

Foundation. In 1989 I joined the Surgical Neurology Branch at the National

Institute of Neurological Disorders and Stroke of the National Institutes

of Health, Bethesda, MD, USA, at first as the International Fogarty Fellow

then as the Clinical Associate and Clinical Staff Researcher. In 2010 I joined

JAMA Editorial Board as the Fishbein Fellow. In 2009 our patent “Nitrite

for vascular diseases” got the “Deal of Distinction” Award. In 2013 I

retired from the National Institute of Health. Over years of my clinical and

research carrier, I presented over 120 lectures at national and international

conferences, over 80 invited lectures andworkshops at the universities and

conferences and published over 130 articles in the leading medical and

scientific journals. I am on the Editorial Board of several leading medical

journals and the reviewer for numerous scientific and medical entities.

e:

ryszardpluta@icloud.com